The company closed its plan on May 23, 2023.
Guangdong Hybribio Biotech Co.,Ltd.
Equities
300639
CNE100002N51
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.51 CNY | -2.98% | +3.99% | -30.30% |
26/04 | Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
24/04 | Guangdong Hybribio Biotech Co.,Ltd. Proposes Final Dividend for the Year 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.30% | 597M | |
-1.29% | 12.64B | |
-0.47% | 8.37B | |
+5.68% | 5.37B | |
+22.61% | 5.26B | |
-2.03% | 4.58B | |
-53.56% | 3.16B | |
+19.30% | 2.89B | |
-8.42% | 2.22B | |
-3.55% | 1.91B |
- Stock Market
- Equities
- 300639 Stock
- News Guangdong Hybribio Biotech Co.,Ltd.
- Guangdong Hybribio Biotech Co.,Ltd.'s Equity Buyback announced on October 26, 2022 has closed with 5,937,000 shares, representing 0.91% for CNY 100 million.